News

Viracor has received EUA from the U.S. Food and Drug Administration (FDA) for their At-Home COVID-19 Nasal PCR Test. The EUA authorized self-collection kit gives consumers a minimally invasive, convenient and quick option to test from the comfort of their home. Results are provided via email within 24 hours of sample receipt.

Since the start of the COVID-19 pandemic, all Invicta FC events have featured testing for athletes, corners, Invicta FC staff and commission officials. Now, leveraging Eurofins’ SAFER@WORK™ protocols, the world’s leading combat sports organization for women has ensured that future events will continue to be a safe environment for all participants.

As part of our continued commitment to providing the highest quality laboratory services, we are investing in people, process and equipment to gain efficiencies for our Coronavirus SARS-CoV-2 testing.

Viracor Eurofins announces research collaboration with the Northwestern University Comprehensive Transplant Center, a leader in solid organ transplantation medicine in North America through high impact research and its clinical training programs. This research collaboration will further verify the novel test obtained through Eurofins’ recent acquisition of Transplant Genomics Inc. (“TGI”), and its blood gene expression test, TruGraf®.

Eurofins U.S. Clinical Diagnostics announced the launch date of its pooled PCR test to detect SARS-CoV-2 and significantly reduce the price per PCR test for clients.  Pooling tests, historically used in blood banks, can now be used by the myriad of industries seeking a highly accurate and cost-effective means to conduct COVID-19 testing. 

Viracor and Transplant Genomics Inc (TGI) announce the formation of the Eurofins Transplant Medical and Scientific Advisory Board, employing diverse expertise and experience in transplantation and technology development to enhance the clinical value of diagnostics throughout the transplant community.

The fragmented U.S. health care system has hampered efforts to expand coronavirus testing, by making it difficult for hospitals to switch to new labs with ample capacity.

Determining how many people may have been exposed to the coronavirus and don't realize it is one of the goals behind antibody testing, which Viracor Eurofins in Lee's Summit started this week.

Antibody testing is a sign that you’ve had the virus in the past,” says Dr. Michelle Altrich. “In order to understand really the number of people that have had the virus, we can now use antibody testing to give us an idea of what that prevalence really looks like.”